Can we predict development of impulsive-compulsive behaviours in Parkinson's disease?

Journal of Neurology, Neurosurgery, and Psychiatry
Lucia RicciardiMark J Edwards

Abstract

To determine clinical and structural imaging predictors of impulsive-compulsive behaviour (ICB) in de novo Parkinson's disease (PD). From a cohort of 1116 subjects from the Parkinson's Progression Marker Initiative database, we created a subcohort of 42 de novo PD without ICB at baseline with available 3T MRI and who developed ICB during follow-up. PD-ICB were matched for age, gender and disease duration to 42 patients with PD without ICB over follow-up (PD-no-ICB) and 42 healthy controls (HCs). Baseline demographic and clinical predictors of ICB were analysed. For the longitudinal neuroimaging analysis, we selected 27 patients with PD-ICB with available neuroimaging after ICB onset, who were matched with 32 PD-no-ICB and 35 HCs. Baseline and longitudinal structural differences were compared using voxel-based morphometry and voxel-based quantification. People who went on to develop ICB had more severe anxiety, worse autonomic and global cognitive functions and were more likely to have rapid eye movement sleep behaviour disorder. Logistic regression confirmed that worse autonomic and cognitive functions were predictors of ICB. We could not find any morphological feature on baseline MRI that predicted later onset of ICB. When com...Continue Reading

References

Jun 16, 2005·NeuroImage·John Ashburner, Karl J Friston
Sep 27, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Karin Stiasny-KolsterWolfgang H Oertel
Mar 8, 2008·NeuroImage·Chloe HuttonRobert Turner
Jul 11, 2008·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·Jeremy D Schmahmann, Deepak N Pandya
Jan 8, 2009·Annals of Neurology·Daniel Weintraub
Feb 11, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Gabriella SantangeloPaolo Barone
May 20, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Daniel WeintraubValerie Voon
Sep 4, 2009·Journal of Neurology·Chiara SiriAngelo Antonini
Jan 11, 2011·NeuroImage·John Ashburner, Karl J Friston
Feb 26, 2011·Brain : a Journal of Neurology·Sean S O'SullivanPaola Piccini
Mar 19, 2011·Annals of Neurology·Valerie VoonMark Stacy
May 5, 2011·Brain Structure & Function·Roberto Cilia, Thilo van Eimeren
Sep 21, 2011·Progress in Neurobiology·UNKNOWN Parkinson Progression Marker Initiative
Nov 20, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Anna Rita BentivoglioAntonio Daniele
Jan 9, 2013·Neurology·Daniel WeintraubUNKNOWN Parkinson's Progression Markers Initiative
Feb 7, 2013·Frontiers in Neuroscience·John Ashburner, Gerard R Ridgway
Jan 1, 2014·Psychiatry Research·Mauro PettorrusoAnna Rita Bentivoglio
Jul 10, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·M L FantiniF Durif
Nov 6, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Daniel WeintraubMark Stacy
Dec 2, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Francesco E PontieriGianfranco Spalletta
Feb 5, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Roberta BiundoAngelo Antonini
Mar 12, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Chiara SiriGianni Pezzoli
Aug 25, 2015·Parkinsonism & Related Disorders·I Aracil-Bolaños, A P Strafella
Nov 5, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·Kara M SmithDaniel Weintraub
Jan 27, 2016·Parkinsonism & Related Disorders·Alessandro TessitoreGioacchino Tedeschi
Mar 5, 2016·Brain : a Journal of Neurology·Christian LambertHugh S Markus
Apr 14, 2016·Current Neurology and Neuroscience Reports·Per BorghammerDavid J Brooks
Sep 4, 2016·Neurology·Francesca MorganteEnza Maria Valente
Sep 11, 2016·Journal of Neurology, Neurosurgery, and Psychiatry·Sean J UdowMario Masellis
Sep 19, 2016·NeuroImage·Christian LambertThomas R Barrick
Mar 1, 2017·Neuroscience and Biobehavioral Reviews·Gabriella SantangeloPaolo Barone
Apr 21, 2017·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M PicilloUNKNOWN PRIAMO Study Group
May 10, 2017·Parkinsonism & Related Disorders·Lucia RicciardiMark J Edwards

❮ Previous
Next ❯

Citations

Mar 18, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Giulia DonzusoMassimo Filippi
Jan 31, 2020·Frontiers in Neurology·Pavlína HlavatáMartin Bareš
Jul 14, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Simona PetrucciUNKNOWN ITA-GENE-PD Study Group
Aug 10, 2019·Current Neurology and Neuroscience Reports·Andreas-Antonios RoussakisPaola Piccini
May 7, 2019·Frontiers in Neurology·Emilia M Gatto, Victoria Aldinio
Dec 24, 2020·Journal of Neurology·Francesca MorganteGiovanni Cossu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.